Search research articles
Contact Us
Filters
Showing results (121-130 of 128) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 128 results.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALS
Jeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
The New England Journal of Medicine
|
September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Muscle & Nerve
|
October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Science Translational Medicine
|
March 31, 2017
Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i>-associated amyotrophic lateral sclerosis
Tania F Gendron, Jeannie Chew, Jeannette N Stankowski, et al.
JAMA Network Open
|
February 17, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
Sabrina Paganoni, Christina N Fournier, Eric A Macklin, et al.
JAMA
|
March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial
, Jeremy M Shefner, Björn Oskarsson, et al.
Neuron
|
March 24, 2018
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
Aude Nicolas, Kevin P Kenna, Alan E Renton, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 128) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 128 results.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALS
Jeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
The New England Journal of Medicine
|
September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Muscle & Nerve
|
October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Science Translational Medicine
|
March 31, 2017
Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i>-associated amyotrophic lateral sclerosis
Tania F Gendron, Jeannie Chew, Jeannette N Stankowski, et al.
JAMA Network Open
|
February 17, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
Sabrina Paganoni, Christina N Fournier, Eric A Macklin, et al.
JAMA
|
March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial
, Jeremy M Shefner, Björn Oskarsson, et al.
Neuron
|
March 24, 2018
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
Aude Nicolas, Kevin P Kenna, Alan E Renton, et al.
Page
of 13